Intriguingly, knockdown of SLC45A4 inhibited cell growth, uptake of glucose and production of ATP in TP53 mutant PDA cells, but not in TP53 wild‐type pancreatic duct cells. This evidence concerns the gene SLC45A4 and Patent ductus arteriosus.